T. Rowe Price Investment Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-670,048	Closed	-$18.6M	–	658
2024 Q4	$18.6M	Sell	670,048 -630,048	-48%	-$17.5M	0.01%	521
2024 Q3	$37.3M	Sell	1,300,096 -467,147	-26%	-$13.4M	0.02%	449
2024 Q2	$41.5M	Buy	1,767,243 +665,194	+60%	+$15.6M	0.03%	415
2024 Q1	$27.8M	Buy	+1,102,049	New	+$27.8M	0.02%	473